News
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) approved Tonmya™ (cyclobenzaprine HCl ...
Zacks Small Cap Research on MSN37m
BLRX: ASCO Poster & Abstract
BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ:BLRX) reported second quarter 2025 results, producing license revenues of $304,000. Following the transition of commercialization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback